Table 1.
Epidemiological data from the total cohort and disease and control subgroups
| Subjects a | Samples | Median age (range) | Sex (m:f) | |||
|---|---|---|---|---|---|---|
| All |
90 |
90 |
33 (16 to 79) |
|
1:3.1 |
|
|
SuS |
25 |
37 |
32 (19 to 62) |
P = n.s.b,d |
1:2.6 |
P = n.s.c,d |
| Definitive SuS |
20 |
32 |
32 (20 to 62) |
|
1:3 |
|
| Limited SuS |
5 |
5 |
30 (19 to 44) |
|
1:1.5 |
|
|
Controls |
70 |
70 |
35 (16 to 79) |
|
1:3.4 |
|
| HC |
20 |
20 |
28 (24 to 50) |
|
1:3 |
|
| MS |
25 |
25 |
35 (21 to 67) |
|
1:2.6 |
|
| CTD | 25 | 25 | 44 (16 to 79) | 1:5.3 |
CTD, connective tissue disorders; HC, healthy controls; MS, multiple sclerosis; n.s., not significant; SuS, Susac syndrome. aAll subjects were of Caucasian origin (SuS: Germany (n = 20), Hungary (n = 2), Spain (n = 1), Canada (n = 1), USA (n = 1); controls: Germany). bMann Whitney U test. cFisher’s exact test. dTotal SuS group vs controls and definite SuS subgroup vs controls.